Figure 2. Ordinal scale categories at consecutive time
points during Delta (D) and Omicron (O) surges in all patients treated
with remdesivir (A), in all patients treated with (RDV) or without
antiviral treatment (NO AVT) during Delta (B) and Omicron (C) surges.
Regardless of which variant of SARS-CoV-2 the patients were infected
with, RDV therapy reduced the risk of death (Figure 2, Table 4).
Table 4. Endpoints of hospitalized patients during Delta and
Omicron waves with regard to RDV treatment.